Kings Path Partners
MLAB icon

Kings Path Partners’s Mesa Laboratories MLAB Stock Holding History

Kings Path Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$316K Hold
2,433
– – 0.08% 94
2026
Q2 		$242K Sell
2,433
-972
-29% -$97.8K 0.06% 106
2026
Q1 		$301K Hold
3,405
– – 0.1% 92
2025
Q4 		$267K Hold
3,405
– – 0.09% 94
2025
Q3 		$228K Hold
3,405
– – 0.08% 95
2025
Q2 		$321K Sell
3,405
-756
-18% -$83K 0.13% 80
2025
Q1 		$494K Sell
4,161
-2,615
-39% -$356K 0.24% 55
2024
Q4 		$894K Hold
6,776
– – 0.38% 68
2024
Q3 		$880K Hold
6,776
– – 0.37% 70
2024
Q2 		$588K Buy
+6,776
New +$710K 0.28% 89

Other funds holding MLAB

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Burns Matteson Capital Management
Burns Matteson Capital Management Corning, New York $289M AUM 39.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Hilltop National Bank
Hilltop National Bank Casper, Wyoming $465M AUM 31.11% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Kings Path Partners's MLAB Position: Q3 2026 in Review

Kings Path Partners held its Mesa Laboratories (MLAB) position steady in Q3 2026 at 2,433 shares worth $316K. The position accounts for 0.08% of the portfolio, ranked #94.

Kings Path Partners first reported a position in MLAB in Q2 2024 and has held it in 10 quarters since. The position peaked at $894K in Q4 2024. 17 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Kings Path Partners held 2,433 shares of Mesa Laboratories worth $316K as of Q3 2026.
  • Kings Path Partners left its Mesa Laboratories share count unchanged in Q3 2026.
  • Mesa Laboratories made up 0.08% of Kings Path Partners's portfolio in Q3 2026, its #94 holding.
  • Kings Path Partners first reported a position in Mesa Laboratories in Q2 2024 and has held it in 10 quarters since.
  • Kings Path Partners's Mesa Laboratories position peaked at $894K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.